Cover Image
Market Research Report
Product code 
1050354

Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032

Published: Pre-Order | DelveInsight Business Research LLP | 200 Pages | Delivery time: 2-10 business days

Price

Back to Top
Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032
Published: Pre-Order
DelveInsight Business Research LLP
Content info: 200 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents
  • List of Tables

DelveInsight's "Osteoarthritis- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Osteoarthritis, historical and forecasted epidemiology as well as the Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Osteoarthritis market report provides current treatment practices, emerging drugs, Osteoarthritis market share of the individual therapies, current and forecasted Osteoarthritis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Osteoarthritis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2019-2032

Osteoarthritis Disease Understanding and Treatment Algorithm

The DelveInsight Osteoarthritis market report gives a thorough understanding of the Osteoarthritis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Osteoarthritis.

Treatment

It covers the details of conventional and current medical therapies available in the Osteoarthritis market for the treatment of the condition. It also provides Osteoarthritis treatment algorithms and guidelines in the United States, Europe, and Japan.

Osteoarthritis Epidemiology

The Osteoarthritis epidemiology division provide insights about historical and current Osteoarthritis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Osteoarthritis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

Country Wise- Osteoarthritis Epidemiology

The epidemiology segment also provides the Osteoarthritis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Osteoarthritis Drug Chapters

Drug chapter segment of the Osteoarthritis report encloses the detailed analysis of Osteoarthritis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Osteoarthritis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Osteoarthritis treatment.

Osteoarthritis Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Osteoarthritis treatment.

Osteoarthritis Market Outlook

The Osteoarthritis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Osteoarthritis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Osteoarthritis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Osteoarthritis market in 7MM is expected to change in the study period 2019-2032.

Key Findings

This section includes a glimpse of the Osteoarthritis market in 7MM.

The United States Market Outlook

This section provides the total Osteoarthritis market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Osteoarthritis market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Osteoarthritis market size and market size by therapies in Japan is also mentioned.

Osteoarthritis Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Osteoarthritis market or expected to get launched in the market during the study period 2019-2032. The analysis covers Osteoarthritis market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Osteoarthritis Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Osteoarthritis key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Osteoarthritis emerging therapies.

Reimbursement Scenario in Osteoarthritis

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Osteoarthritis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Osteoarthritis market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Osteoarthritis Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

  • The report covers the descriptive overview of Osteoarthritis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Osteoarthritis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Osteoarthritis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Osteoarthritis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Osteoarthritis market

Report Highlights:

  • In the coming years, Osteoarthritis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Osteoarthritis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for Osteoarthritis. Launch of emerging therapies will significantly impact the Osteoarthritis market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Osteoarthritis
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Osteoarthritis Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Osteoarthritis Pipeline Analysis
  • Osteoarthritis Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Osteoarthritis Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage
  • Osteoarthritis Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

Osteoarthritis Report Assessment

Current Treatment Practices

  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Questions

Market Insights:

  • What was the Osteoarthritis market share (%) distribution in 2019 and how it would look like in 2032?
  • What would be the Osteoarthritis total market size as well as market size by therapies across the 7MM during the forecast period (2019-2032)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Osteoarthritis market size during the forecast period (2019-2032)?
  • At what CAGR, the Osteoarthritis market is expected to grow in 7MM during the forecast period (2019-2032)?
  • What would be the Osteoarthritis market outlook across the 7MM during the forecast period (2019-2032)?
  • What would be the Osteoarthritis market growth till 2032, and what will be the resultant market Size in the year 2032?
  • How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

  • What is the disease risk, burden and unmet needs of the Osteoarthritis?
  • What is the historical Osteoarthritis patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of Osteoarthritis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Osteoarthritis?
  • Out of all 7MM countries, which country would have the highest prevalent population of Osteoarthritis during the forecast period (2019-2032)?
  • At what CAGR the population is expected to grow in 7MM during the forecast period (2019-2032)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

  • What are the current options for the Osteoarthritis treatment, along with the approved therapy?
  • What are the current treatment guidelines for the treatment of Osteoarthritis in the USA, Europe, and Japan?
  • What are the Osteoarthritis marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
  • How many companies are developing therapies for the treatment of Osteoarthritis?
  • How many therapies are developed by each company for Osteoarthritis treatment?
  • How many are emerging therapies in mid-stage, and late stage of development for Osteoarthritis treatment?
  • What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Osteoarthritis therapies?
  • What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Osteoarthritis and their status?
  • What are the key designations that have been granted for the emerging therapies for Osteoarthritis?
  • What are the global historical and forecasted market of Osteoarthritis?

Reasons to buy:

  • The report will help in developing business strategies by understanding trends shaping and driving the Osteoarthritis market
  • To understand the future market competition in the Osteoarthritis market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Osteoarthritis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Osteoarthritis market
  • To understand the future market competition in the Osteoarthritis market
Product Code: DIMI0329

Table of Contents

1. Key Insights

2. Executive Summary of Osteoarthritis

3. Competitive Intelligence Analysis for Osteoarthritis

4. Osteoarthritis: Market Overview at a Glance

  • 4.1. Osteoarthritis Total Market Share (%) Distribution in 2019
  • 4.2. Osteoarthritis Total Market Share (%) Distribution in 2032

5. Osteoarthritis: Disease Background and Overview

  • 5.1. Introduction
  • 5.2. Sign and Symptoms
  • 5.3. Pathophysiology
  • 5.4. Risk Factors
  • 5.5. Diagnosis

6. Patient Journey

7. Osteoarthritis Epidemiology and Patient Population

  • 7.1. Epidemiology Key Findings
  • 7.2. Assumptions and Rationale: 7MM
  • 7.3. Epidemiology Scenario: 7MM
    • 7.3.1. Osteoarthritis Epidemiology Scenario in the 7MM (2019-2032)
  • 7.4. United States Epidemiology
    • 7.4.1. Osteoarthritis Epidemiology Scenario in the United States (2019-2032)
  • 7.5. EU-5 Country-wise Epidemiology
    • 7.5.1. Germany Epidemiology
      • 7.5.1.1. Osteoarthritis Epidemiology Scenario in Germany (2019-2032)
    • 7.5.2. France Epidemiology
      • 7.5.2.1. Osteoarthritis Epidemiology Scenario in France (2019-2032)
    • 7.5.3. Italy Epidemiology
      • 7.5.3.1. Osteoarthritis Epidemiology Scenario in Italy (2019-2032)
    • 7.5.4. Spain Epidemiology
      • 7.5.4.1. Osteoarthritis Epidemiology Scenario in Spain (2019-2032)
    • 7.5.5. United Kingdom Epidemiology
      • 7.5.5.1. Osteoarthritis Epidemiology Scenario in the United Kingdom (2019-2032)
    • 7.5.6. Japan Epidemiology
      • 7.5.6.1. Osteoarthritis Epidemiology Scenario in Japan (2019-2032)

8. Treatment Algorithm, Current Treatment, and Medical Practices

  • 8.1. Osteoarthritis Treatment and Management
  • 8.2. Osteoarthritis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Osteoarthritis Treatment

11. Marketed Products

  • 11.1. List of Marketed Products in the 7MM
  • 11.2. Drug Name: Company Name
    • 11.2.1. Product Description
    • 11.2.2. Regulatory Milestones
    • 11.2.3. Other Developmental Activities
    • 11.2.4. Pivotal Clinical Trials
    • 11.2.5. Summary of Pivotal Clinical Trial
  • List to be continued in report

12. Emerging Therapies

  • 12.1. Key Cross
  • 12.2. Drug Name: Company Name
    • 12.2.1. Product Description
    • 12.2.2. Other Developmental Activities
    • 12.2.3. Clinical Development
    • 12.2.4. Safety and Efficacy
    • 12.2.5. Product Profile
  • List to be continued in report

13. Osteoarthritis: Seven Major Market Analysis

  • 13.1. Key Findings
  • 13.2. Osteoarthritis Market Size in 7MM
  • 13.3. Osteoarthritis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

  • 15.1. United States: Market Size
    • 15.1.1. Osteoarthritis Total Market Size in the United States
    • 15.1.2. Osteoarthritis Market Size by Therapies in the United States
  • 15.2. EU-5 countries: Market Size and Outlook
  • 15.3. Germany Market Size
    • 15.3.1. Osteoarthritis Total Market Size in Germany
    • 15.3.2. Osteoarthritis Market Size by Therapies in Germany
  • 15.4. France Market Size
    • 15.4.1. Osteoarthritis Total Market Size in France
    • 15.4.2. Osteoarthritis Market Size by Therapies in France
  • 15.5. Italy Market Size
    • 15.5.1. Osteoarthritis Total Market Size in Italy
    • 15.5.2. Osteoarthritis Market Size by Therapies in Italy
  • 15.6. Spain Market Size
    • 15.6.1. Osteoarthritis Total Market Size in Spain
    • 15.6.2. Osteoarthritis Market Size by Therapies in Spain
  • 15.7. United Kingdom Market Size
    • 15.7.1. Osteoarthritis Total Market Size in the United Kingdom
    • 15.7.2. Osteoarthritis Market Size by Therapies in the United Kingdom
  • 15.8. Japan Market Outlook
    • 15.8.1. Japan Market Size
    • 15.8.2. Osteoarthritis Total Market Size in Japan
    • 15.8.3. Osteoarthritis Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Osteoarthritis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

  • 20.1. Bibliography
  • 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

  • The table of contents is not exhaustive; the final content may vary.

List of Tables

  • Table 1: 7MM Osteoarthritis Epidemiology (2019-2032)
  • Table 2: 7MM Osteoarthritis Diagnosed and Treatable Cases (2019-2032)
  • Table 3: Osteoarthritis Epidemiology in the United States (2019-2032)
  • Table 4: Osteoarthritis Diagnosed and Treatable Cases in the United States (2019-2032)
  • Table 5: Osteoarthritis Epidemiology in Germany (2019-2032)
  • Table 6: Osteoarthritis Diagnosed and Treatable Cases in Germany (2019-2032)
  • Table 7: Osteoarthritis Epidemiology in France (2019-2032)
  • Table 8: Osteoarthritis Diagnosed and Treatable Cases in France (2019-2032)
  • Table 9: Osteoarthritis Epidemiology in Italy (2019-2032)
  • Table 10: Osteoarthritis Diagnosed and Treatable Cases in Italy (2019-2032)
  • Table 11: Osteoarthritis Epidemiology in Spain (2019-2032)
  • Table 12: Osteoarthritis Diagnosed and Treatable Cases in Spain (2019-2032)
  • Table 13: Osteoarthritis Epidemiology in the UK (2019-2032)
  • Table 14: Osteoarthritis Diagnosed and Treatable Cases in the UK (2019-2032)
  • Table 15: Osteoarthritis Epidemiology in Japan (2019-2032)
  • Table 16: Osteoarthritis Diagnosed and Treatable Cases in Japan (2019-2032)
  • Table 17: Drug Name, Clinical Trials by Recruitment status
  • Table 18: Drug Name, Clinical Trials by Zone
  • Table 19: Total Seven Major Market Size in USD, Million (2019-2032)
  • Table 20: Region-wise Market Size in USD, Million (2019-2032)
  • Table 21: 7MM-Market Size by Therapy in USD, Million (2019-2032)
  • Table 22: United States Market Size in USD, Million (2019-2032)
  • Table 23: United States Market Size by Therapy in USD, Million (2019-2032)
  • Table 24: Germany Market Size in USD, Million (2019-2032)
  • Table 25: Germany Market Size by Therapy in USD, Million (2019-2032)
  • Table 26: France Market Size in USD, Million (2019-2032)
  • Table 27: France Market Size by Therapy in USD, Million (2019-2032)
  • Table 28: Italy Market Size in USD, Million (2019-2032)
  • Table 29: Italy Market Size by Therapy in USD, Million (2019-2032)
  • Table 30: Spain Market Size in USD, Million (2019-2032)
  • Table 31: Spain Market Size by Therapy in USD, Million (2019-2032)
  • Table 32: United Kingdom Market Size in USD, Million (2019-2032)
  • Table 33: United Kingdom Market Size by Therapy in USD, Million (2019-2032)
  • Table 34: Japan Market Size in USD, Million (2019-2032)
  • Table 35: Japan Market Size by Therapy in USD, Million (2019-2032)

The list of tables is not exhaustive; the final content may vary

List of Figures

  • Figure 1: 7MM Osteoarthritis Epidemiology (2019-2032)
  • Figure 2: 7MM Osteoarthritis Diagnosed and Treatable Cases (2019-2032)
  • Figure 3: Osteoarthritis Epidemiology in the United States (2019-2032)
  • Figure 4: Osteoarthritis Diagnosed and Treatable Cases in the United States (2019-2032)
  • Figure 5: Osteoarthritis Epidemiology in Germany (2019-2032)
  • Figure 6: Osteoarthritis Diagnosed and Treatable Cases in Germany (2019-2032)
  • Figure 7: Osteoarthritis Epidemiology in France (2019-2032)
  • Figure 8: Osteoarthritis Diagnosed and Treatable Cases in France (2019-2032)
  • Figure 9: Osteoarthritis Epidemiology in Italy (2019-2032)
  • Figure 10: Osteoarthritis Diagnosed and Treatable Cases in Italy (2019-2032)
  • Figure 11: Osteoarthritis Epidemiology in Spain (2019-2032)
  • Figure 12: Osteoarthritis Diagnosed and Treatable Cases in Spain (2019-2032)
  • Figure 13: Osteoarthritis Epidemiology in the UK (2019-2032)
  • Figure 14: Osteoarthritis Diagnosed and Treatable Cases in the UK (2019-2032)
  • Figure 15: Osteoarthritis Epidemiology in Japan (2019-2032)
  • Figure 16: Osteoarthritis Diagnosed and Treatable Cases in Japan (2019-2032)
  • Figure 17: Drug Name, Clinical Trials by Recruitment status
  • Figure 18: Drug Name, Clinical Trials by Zone
  • Figure 19: Total Seven Major Market Size in USD, Million (2019-2032)
  • Figure 20: Region-wise Market Size in USD, Million (2019-2032)
  • Figure 21: 7MM-Market Size by Therapy in USD, Million (2019-2032)
  • Figure 22: United States Market Size in USD, Million (2019-2032)
  • Figure 23: United States Market Size by Therapy in USD, Million (2019-2032)
  • Figure 24: Germany Market Size in USD, Million (2019-2032)
  • Figure 25: Germany Market Size by Therapy in USD, Million (2019-2032)
  • Figure 26: France Market Size in USD, Million (2019-2032)
  • Figure 27: France Market Size by Therapy in USD, Million (2019-2032)
  • Figure 28: Italy Market Size in USD, Million (2019-2032)
  • Figure 29: Italy Market Size by Therapy in USD, Million (2019-2032)
  • Figure 30: Spain Market Size in USD, Million (2019-2032)
  • Figure 31: Spain Market Size by Therapy in USD, Million (2019-2032)
  • Figure 32: United Kingdom Market Size in USD, Million (2019-2032)
  • Figure 33: United Kingdom Market Size by Therapy in USD, Million (2019-2032)
  • Figure 34: Japan Market Size in USD, Million (2019-2032)
  • Figure 35: Japan Market Size by Therapy in USD, Million (2019-2032)

The list of figures is not exhaustive; the final content may vary